Company / PP&E per Share
Enliven Therapeutics, Inc. PP&E per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2024
5-year range
$0.01 / $0.28
FY2020-FY2024
Trend
-53.4%
vs FY2023
Sector context
#160 of 191
Health Care
What the data says
Enliven Therapeutics, Inc.'s pp&e per share of $0.01 is lower than 84% of companies in the Health Care sector (FY2024). Declined from $0.28 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of -56.6%.
Declined from $0.28 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -5.5%
- 5-Year CAGR
- -56.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 191This company $0.01 Sector average $18.90
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 53.4% year-over-year.
- Ranks #160 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.84 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | -53.4% |
| FY2023 | $0.02 | -92.7% |
| FY2022 | $0.28 | +2368.2% |
| FY2021 | $0.01 | -54.0% |
| FY2020 | $0.03 | -96.0% |
| FY2019 | $0.63 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026